About Neuland
Our Company
Neuland is a leading Hyderabad based manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry for chemistry related services. We are more than 1000 employees strong and our core competence lies in the application of strong process chemistry to manufacturing in regulatory environment.
For 25 years, Neuland has been at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company’s technical and scientific teams provide reliable solutions and services to the global pharmaceutical industry.
The organization's strength lies in its ability to partner with companies (over 700 customers spread across the globe) from early stage and throughout the life cycle of the products, with speed and efficiency in order to maintain their competitiveness.
Our Businesses
Manufacture of APIs We have developed processes for over 50 APIs across various therapeutic categories in the laboratory and scaled them up to plant scale, and selling them to over 700 customers in 80 countries. Since the last decade, we have been selling in the regulated markets.
Contract Research & Contract Manufacturing Since 2000, Neuland has been offering Contract Research & Contract Manufacturing Services. Neuland's customers include Large MNC's; mid-sized pharmaceutical companies; stand-alone Research organizations as well as large Generic companies. Currently we are working with more than 20 companies worldwide.
Clinical Research Clinical research services are being developed as a joint venture with US-based Cato Research Inc. to conduct clinical trials in India. Cato Research has some of the best names in the pharmaceutical industry as its clients, and Neuland would be supporting the execution of the clinical trials. Initially, the joint venture company will conduct phase II and III trials in areas such as diabetes, dermatology, oncology and other therapeutic segments.
Our markets
Neuland has meaningful footprints in several countries with more than 80% of the revenues accounted for by exports in 2009-10. US and Europe are our key markets, accounting for 75 % of total exports.
The Company has filed 33 DMFs with the USFDA and over 350 DMFs with various health authorities in Europe, Canada, Japan, Korea and Australia.
Our top ten products
The Company is present in eight major therapeutic categories including cardiovascular, central nervous systems, anti-invectives, anti-asthmatics, anti-fungal, anti-ulcerants and anti-spasmodic.
The top 10 products of the Company are:- Ciprofloxacin HCl
- Mirtazapine
- Ranitidine HCl
- Enalapril Maleate
- Ramipril
- Sotalol HCl
- Olanzapine
- Ipratropium Bromide
- Itraconazole
- Salmeterol
Our production facilities
Neuland has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions. The manufacturing facilities for the APIs comply with stringent guidelines & requirements of Good Manufacturing Practices (GMP) and have been inspected by international health and regulatory agencies such as the USFDA, EDQM, BfArM (Germany), KFDA (Korea) and PMDA (Japan).